Abbvie reported $26B in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
ALKERMES ALKS:US 1.05B 15.25M
Amgen AMGN:US $ 24380M 5281M
AstraZeneca AZN:LN 26.69B 583M
Astrazeneca AZN:US 26.69B 583M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Chemocentryx CCXI:US $ 293.38M 23.75M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
Infinity Pharmaceuticals INFI:US $ 91.93M 7.75M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Medtronic MDT:US $ 22731M 297M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Perrigo Ordinary Shares PRGO:US $ 4225.9M 194.3M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
United Therapeutics UTHR:US $ 2385.9M 68M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Zoetis ZTS:US $ 6682M 366M